Literature DB >> 10845390

Prognostic value of proliferation index and expression of the RNA component of human telomerase (hTR) in papillary meningiomas.

E J Rushing1, S M Colvin, A Gazdar, N Miura, C L White, C Coimbra, D K Burns.   

Abstract

Papillary meningioma is a rare subtype of meningioma that often behaves aggressively. In order to characterize factors that may influence this behavior, we chose to compare MIB-1 labeling index (LI) and telomerase RNA localization (hTR) in papillary meningiomas, meningiomas, and atypical meningiomas. LI is now often used to supplement histologic grade in the evaluation of these lesions. More recent studies indicate that increased expression of hTR is detected in many neoplastic cells, and may play an essential role in cell immortalization. The study group consisted of five papillary meningiomas (and a recurrence in one case), 11 conventional meningiomas, and eight atypical meningiomas. Conventional meningiomas showed either negative or 1 + hTR. Atypical meningiomas showed 1 + hTR. Papillary meningiomas showed the highest hTR (five of six, including recurrence, 2-3+ and one 1+). Generally, the LI was very low for conventional meningiomas (< 2%). The LI of atypical meningiomas ranged from 3-19%, mean 12%, and from 5.5-17.5%, mean 11.75% for papillary meningiomas. LI differentiated between meningiomas, and papillary or atypical meningiomas. hTR further delineated papillary (moderate to high) from atypical meningiomas (low). The combined variable of LI and hTR expression could be a useful independent prognostic indicator in patients with papillary meningioma.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10845390     DOI: 10.1023/a:1006353322307

Source DB:  PubMed          Journal:  J Neurooncol        ISSN: 0167-594X            Impact factor:   4.130


  41 in total

1.  No prediction of recurrence of meningiomas by PCNA and Ki-67 immunohistochemistry.

Authors:  M L Møller; O Braendstrup
Journal:  J Neurooncol       Date:  1997-09       Impact factor: 4.130

2.  Telomerase activity in human germline and embryonic tissues and cells.

Authors:  W E Wright; M A Piatyszek; W E Rainey; W Byrd; J W Shay
Journal:  Dev Genet       Date:  1996

3.  Telomerase expression in respiratory epithelium during the multistage pathogenesis of lung carcinomas.

Authors:  K Yashima; L A Litzky; L Kaiser; T Rogers; S Lam; I I Wistuba; S Milchgrub; S Srivastava; M A Piatyszek; J W Shay; A F Gazdar
Journal:  Cancer Res       Date:  1997-06-15       Impact factor: 12.701

Review 4.  Telomeres, telomerase, and immortality.

Authors:  M S Rhyu
Journal:  J Natl Cancer Inst       Date:  1995-06-21       Impact factor: 13.506

5.  The significant role of telomerase activity in human brain tumors.

Authors:  K Nakatani; N Yoshimi; H Mori; S Yoshimura; H Sakai; J Shinoda; N Sakai
Journal:  Cancer       Date:  1997-08-01       Impact factor: 6.860

Review 6.  Primary papillary meningioma of the optic nerve sheath: a case of unique location and benign pathology.

Authors:  S Shuangshoti
Journal:  Surg Neurol       Date:  1993-03

7.  Telomerase activity: a prevalent marker of malignant human prostate tissue.

Authors:  H J Sommerfeld; A K Meeker; M A Piatyszek; G S Bova; J W Shay; D S Coffey
Journal:  Cancer Res       Date:  1996-01-01       Impact factor: 12.701

Review 8.  Defining the molecular mechanisms of human cell immortalization.

Authors:  J W Shay; W E Wright; H Werbin
Journal:  Biochim Biophys Acta       Date:  1991-04-16

9.  Correlating telomerase activity levels with human neuroblastoma outcomes.

Authors:  E Hiyama; K Hiyama; T Yokoyama; Y Matsuura; M A Piatyszek; J W Shay
Journal:  Nat Med       Date:  1995-03       Impact factor: 53.440

10.  Papillary meningioma.

Authors:  S Z Stefanko; W M Mackay
Journal:  Acta Neuropathol Suppl       Date:  1981
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.